Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Sight OLO-E1/U1 Software and Operators Manual Software v2.56.1 Catalog #: 1 OLO-U1 Catalog #: 2 OLO-E1 revision 1.9, revision 1.10

FDA Recall Z-2517-2021 · Posted None

Recalling FirmSIGHT DIAGNOSTICS LTD
Recall StatusTerminated
Product CodeGKZ
Date Initiated2021-03-17
Date Terminated2022-06-08
Product Quantity114 units

Reason for Recall

Discrepancy in labeling between the adult CBC reference ranges presented in the OLO Operator's Manual and the OLO software

Firm Action

Sight Diagnosics issued URGENT 2021-03-16 Medical Device Recall Notification on 3/15/21 via email. Letter states reason for recall, health risk and action to take: Corrective and Preventive Actions Taken by the Company: Section 5.7.1 of both OLO-E1 and OLO-U1 Operator s Manuals has been updated to reflect the adult reference ranges verified by Sight. Software version v2.56.1 was updated to software version v2.56.2, which is configured (by default) with the adult reference ranges verified by Sight. Actions to be taken by the customer: Please discard all previous Operator's Manuals in your possession. Attached to this recall notification is the OLO Operators Manual, rev. 1.14 (U1) and 1.15 (E1). The updated Operator's Manual includes Sights verified reference ranges. Each laboratory should either validate these ranges or establish their own in accordance with their state and regulatory agency guidelines. The software version of the OLO analyzer in your possession will be updated to a new version that includes the above mentioned correction. The update will be performed remotely by Sight's product specialists, who will contact you in the coming month to schedule the update. Please be aware that the software version update requires the analyzer to be connected to the internet. If you are a distributor, please provide a copy of this recall notification and updated Operator s Manual to any customer whom the product was shipped to, or may have been shipped to. If you have been authorised by Sight to translate the Operator s Manual, please make sure you update the Operator s Manual s translation accordingly. You are kindly requested to fill the attached Acknowledgement and Receipt Form, and return it to Sight [email protected] within 30 days. If you are required to notify your local authority, please use this notification letter and inform Sight as soon as possible. If you have any questions please contact us at [email protected]. For full indicati

Root Cause

Labeling Change Control

Distribution Pattern

Worldwide distribution - US Nationwide distribution in the states of Alabama, Florida, Massachusetts, Minnesota, Missouri, New York, Ohio, Texas, Virginia, Washington and the countries of AUSTRALIA, CHILE, UNITED KINGDOM, GEORGIA, ISRAEL, Mexico, NETHERLANDS, Portugal, Russia, Singapore, Thailand.

Related FDA 510(k) Records

Devices referenced by this recall via K-numbers.

K190898Sight OLOSight Diagnostics , Ltd. · 2019-11-01

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑